Pediatrix Medical Group Inc (MD)
ROA
Obliczenia
|
2023/Q4 (31 gru 2023) |
2023/Q3 (30 wrz 2023) |
2023/Q2 (30 cze 2023) |
2023/Q1 (31 mar 2023) |
2022/Q4 (31 gru 2022) |
2022/Q3 (30 wrz 2022) |
2022/Q2 (30 cze 2022) |
2022/Q1 (31 mar 2022) |
||
|---|---|---|---|---|---|---|---|---|---|
| Zysk netto (ttm) | w tys. USD | -60 408 | 93 538 | 102 875 | 101 729 | 66 335 | 84 192 | 84 259 | 92 134 |
| Aktywa razem | w tys. USD | 2 219 810 | 2 326 340 | 2 305 510 | 2 320 050 | 2 347 890 | 2 331 960 | 2 369 620 | 2 340 980 |
| ROA | -2,72% | 4,02% | 4,46% | 4,38% | 2,83% | 3,61% | 3,56% | 3,94% |
2023/Q4 obliczenia
ROA = Zysk netto (ttm) ÷ Aktywa razem
= $-60 408K ÷ $2 219 810K
= -2,72%
Analiza porównawcza
2023/Q4
Nazwa spółki
Symbol
ROA
Pediatrix Medical Group Inc
MD
-2,72%
Acadia Healthcare Company Inc
ACHC
-0,40%
Encompass Health Corp
EHC
5,73%
Ensign Group Inc
ENSG
5,01%
HCA Healthcare Inc
HCA
9,33%
National Healthcare Corp.
NHC
5,10%
Select Medical Holdings Corporation
SEM
3,05%
Tenet Healthcare Corp.
THC
2,16%
Universal Health Services, Inc.
UHS
5,14%